Today Zomedica Pharmaceuticals Corphares (NYSEAMERICAN:ZOM) Reported Increase in Shorted Shares

June 16, 2018 - By Peter Erickson

The stock of Zomedica Pharmaceuticals Corphares (NYSEAMERICAN:ZOM) registered an increase of 17.49% in short interest. ZOM’s total short interest was 52,400 shares in June as published by FINRA. Its up 17.49% from 44,600 shares, reported previously. With 13,200 shares average volume, it will take short sellers 4 days to cover their ZOM’s short positions. The short interest to Zomedica Pharmaceuticals Corphares’s float is 0.24%.

The stock decreased 8.38% or $0.16 during the last trading session, reaching $1.75. About 93,938 shares traded or 372.48% up from the average. Zomedica Pharmaceuticals Corp. (NYSEAMERICAN:ZOM) has 0.00% since June 16, 2017 and is . It has underperformed by 12.57% the S&P500.

Zomedica Pharmaceuticals Corp. operates as a veterinary pharmaceutical firm in the United States. The company has market cap of $161.79 million. It focuses on the discovery, development, and commercialization of drugs, novel drug delivery systems, devices, and diagnostics for the health and wellness of companion animals, such as canine, feline, and equine. It currently has negative earnings. The firm has a research collaboration agreement with Celsee Diagnostics, Inc. to test the feasibility of Celsee's liquid biopsy technology for veterinary application as a canine cancer diagnostics.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: